Shire

Shire Plc Chief Executive Officer Flemming Ornskov Interview
Health

UPDATED: Rare Disease Drug Maker Shire’s Stock Spikes Amid Possible Bidding War Between Allergan and Takeda

By
April 19, 2018
AbbVie Inc. To Buy Shire For $54.8 Billion
Health

Drugmaker Shire Is Buying Baxalta for $32 Billion

By
January 11, 2016
AbbVie Inc. To Buy Shire For $54.8 Billion
International

Shire-Baxalta $32 Billion Merger Talks Said to Advance

By
January 3, 2016
Shire Plc's U.K. Offices As Drugmaker Rejects Abbvie Inc.'s $46.5 Billion Offer
Health

Shire offers to buy rival drugmaker Baxalta for $30 billion

By
August 4, 2015
Traders At The NYSE React To Malaysian Airliner Crash In Ukraine
Finance

Markets end week with a rally, despite geopolitical turmoil

By
July 18, 2014
Fortune
Finance

Are U.S. corporate tax inversions a necessary crisis?

By
July 18, 2014

Most Popular